NO983776D0 - 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister - Google Patents
1,4-Dihydropyridin-forbindelser som Bradykinin-antagonisterInfo
- Publication number
- NO983776D0 NO983776D0 NO983776A NO983776A NO983776D0 NO 983776 D0 NO983776 D0 NO 983776D0 NO 983776 A NO983776 A NO 983776A NO 983776 A NO983776 A NO 983776A NO 983776 D0 NO983776 D0 NO 983776D0
- Authority
- NO
- Norway
- Prior art keywords
- bradykinin antagonists
- dihydropyridine compounds
- dihydropyridine
- compounds
- bradykinin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9600132 | 1996-02-19 | ||
| PCT/IB1997/000058 WO1997030048A1 (en) | 1996-02-19 | 1997-01-27 | 1,4-dihydropyridine compounds as bradykinin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983776L NO983776L (no) | 1998-08-18 |
| NO983776D0 true NO983776D0 (no) | 1998-08-18 |
Family
ID=11004406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983776A NO983776D0 (no) | 1996-02-19 | 1998-08-18 | 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6131226A (no) |
| EP (1) | EP0882044B1 (no) |
| JP (1) | JP3167335B2 (no) |
| KR (1) | KR19990082678A (no) |
| CN (1) | CN1211251A (no) |
| AR (1) | AR005841A1 (no) |
| AT (1) | ATE220676T1 (no) |
| AU (1) | AU1396497A (no) |
| BG (1) | BG102678A (no) |
| BR (1) | BR9707568A (no) |
| CA (1) | CA2245857C (no) |
| CO (1) | CO4650041A1 (no) |
| CZ (1) | CZ258698A3 (no) |
| DE (1) | DE69714019T2 (no) |
| DK (1) | DK0882044T3 (no) |
| ES (1) | ES2177921T3 (no) |
| HN (1) | HN1997000013A (no) |
| HR (1) | HRP970094A2 (no) |
| HU (1) | HUP9902810A3 (no) |
| ID (1) | ID16434A (no) |
| IL (1) | IL124867A0 (no) |
| IS (1) | IS4783A (no) |
| MA (1) | MA26419A1 (no) |
| NO (1) | NO983776D0 (no) |
| NZ (1) | NZ325455A (no) |
| OA (1) | OA10712A (no) |
| PE (1) | PE36298A1 (no) |
| PL (1) | PL328514A1 (no) |
| PT (1) | PT882044E (no) |
| SI (1) | SI0882044T1 (no) |
| TN (1) | TNSN97037A1 (no) |
| TR (1) | TR199801593T2 (no) |
| WO (1) | WO1997030048A1 (no) |
| ZA (1) | ZA971357B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11106375A (ja) * | 1997-08-18 | 1999-04-20 | Pfizer Pharmaceut Inc | ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物 |
| US6653313B2 (en) * | 2000-08-10 | 2003-11-25 | Warner-Lambert Company Llc | 1,4-dihydropyridine compounds as bradykinin antagonists |
| GB0427281D0 (en) * | 2004-12-14 | 2005-01-12 | 3M Innovative Properties Co | Methods of providing medicinal metal components having through holes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120750A (en) * | 1989-01-17 | 1992-06-09 | Synphar Laboratories, Inc. | Generation of 1,4-dihydropyridine derivatives |
| WO1996006083A1 (en) * | 1994-08-24 | 1996-02-29 | Pfizer Pharmaceuticals Inc. | 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| MX9701245A (es) * | 1996-02-19 | 1998-04-30 | Pfizer | Compuestos de 1,4 dihidropiridina. |
-
1996
- 1996-02-18 TN TNTNSN97037A patent/TNSN97037A1/fr unknown
-
1997
- 1997-01-27 BR BR9707568A patent/BR9707568A/pt active Search and Examination
- 1997-01-27 HN HN1997000013A patent/HN1997000013A/es unknown
- 1997-01-27 WO PCT/IB1997/000058 patent/WO1997030048A1/en active IP Right Grant
- 1997-01-27 DK DK97900401T patent/DK0882044T3/da active
- 1997-01-27 PT PT97900401T patent/PT882044E/pt unknown
- 1997-01-27 AT AT97900401T patent/ATE220676T1/de not_active IP Right Cessation
- 1997-01-27 CA CA002245857A patent/CA2245857C/en not_active Expired - Fee Related
- 1997-01-27 ES ES97900401T patent/ES2177921T3/es not_active Expired - Lifetime
- 1997-01-27 CZ CZ982586A patent/CZ258698A3/cs unknown
- 1997-01-27 DE DE69714019T patent/DE69714019T2/de not_active Expired - Fee Related
- 1997-01-27 NZ NZ325455A patent/NZ325455A/xx unknown
- 1997-01-27 HU HU9902810A patent/HUP9902810A3/hu unknown
- 1997-01-27 IL IL12486797A patent/IL124867A0/xx unknown
- 1997-01-27 EP EP97900401A patent/EP0882044B1/en not_active Expired - Lifetime
- 1997-01-27 SI SI9730361T patent/SI0882044T1/xx unknown
- 1997-01-27 US US09/125,137 patent/US6131226A/en not_active Expired - Fee Related
- 1997-01-27 PL PL97328514A patent/PL328514A1/xx unknown
- 1997-01-27 CN CN97192240A patent/CN1211251A/zh active Pending
- 1997-01-27 TR TR1998/01593T patent/TR199801593T2/xx unknown
- 1997-01-27 JP JP52913897A patent/JP3167335B2/ja not_active Expired - Fee Related
- 1997-01-27 KR KR1019980706424A patent/KR19990082678A/ko not_active Application Discontinuation
- 1997-01-27 AU AU13964/97A patent/AU1396497A/en not_active Abandoned
- 1997-02-10 PE PE1997000085A patent/PE36298A1/es not_active Application Discontinuation
- 1997-02-13 CO CO97007547A patent/CO4650041A1/es unknown
- 1997-02-17 AR ARP970100614A patent/AR005841A1/es unknown
- 1997-02-18 ID IDP970467A patent/ID16434A/id unknown
- 1997-02-18 HR HRPCT/IB96/00132A patent/HRP970094A2/xx not_active Application Discontinuation
- 1997-02-18 MA MA24498A patent/MA26419A1/fr unknown
- 1997-02-18 ZA ZA971357A patent/ZA971357B/xx unknown
-
1998
- 1998-06-25 IS IS4783A patent/IS4783A/is unknown
- 1998-07-10 OA OA9800111A patent/OA10712A/en unknown
- 1998-08-10 BG BG102678A patent/BG102678A/xx unknown
- 1998-08-18 NO NO983776A patent/NO983776D0/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID17259A (id) | Fluorina mengandung turunan piperidina 1,4-disubtitusikan | |
| ATE340176T1 (de) | Substituierte 6,5-heterobicyclische-derivate | |
| NO990892L (no) | Substituerte 6,6-hetero-bicykliske derivater | |
| NO2006016I1 (no) | 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat | |
| PT993456E (pt) | 4,5-diaril-imidazoles 2-substituidos | |
| BR9707786B1 (pt) | composto. | |
| ID29241A (id) | Turunan-turunan kinolin teranelasi-1,2 | |
| DE19581637T1 (de) | Multifunktionelle, biologisch dispergierende/biozide Zusammensetzungen | |
| DK1000048T3 (da) | Substituerede 1,2,3,4-tetrahydronapthalenderivater | |
| DE69718771D1 (de) | Substituierte 1,2,3,4-tetrahydronaphthalinderivate | |
| DK0871623T3 (da) | 3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister | |
| ID26909A (id) | Turunan-turunan 1,3,4-oksadiazolon | |
| DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
| DK1086093T3 (da) | Tetrahydroquinolinderivater som glycinantagonister | |
| BR9711977A (pt) | Composi-{es biocidas | |
| ATE234839T1 (de) | 4,5-azolo-oxindole | |
| NO995782L (no) | Kvarternaere ammoniumforbindelser som tachykinin-antagonister | |
| DK0882044T3 (da) | 1,4-dihydropyridinforbindelser som bradykinin-antagonister | |
| NO20002575D0 (no) | Substituerte oksimer som neurokininantagonister | |
| DK1068200T3 (da) | 2,4,4-trisubstituerede-1,3-dioxolanfungicider | |
| ID24047A (id) | Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on | |
| ATE240941T1 (de) | 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate | |
| DE69908923D1 (de) | 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen | |
| FR2718422B1 (fr) | Magasin rotatif horizontal. | |
| BR9700358A (pt) | Andaime 2.000 |